The takeaway
Incyte Corporation shows a moderate seasonal pattern over 10 years of data — strongest in June (+1.0%) and softest in September (−4.6%).
Right now
In July, the stock has risen 60% of years, averaging +2.0% — essentially in line with the S&P 500.
The full picture
Incyte Corporation's most dependable month has been June, higher in 7 of 10 years; September has been its least reliable, up just 10% of the time.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Win rate % | ||||||||||||
| Median return % | ||||||||||||
| 2025 | ||||||||||||
| 2024 | ||||||||||||
| 2023 | ||||||||||||
| 2022 | ||||||||||||
| 2021 | ||||||||||||
| 2020 | ||||||||||||
| 2019 | ||||||||||||
| 2018 | ||||||||||||
| 2017 | ||||||||||||
| 2016 |
Month by month
The stock's clearest edge over the S&P 500 lands in May (+2.1 pts); it has trailed the market most in September (−4.4 pts).
“vs S&P” is Incyte Corporation’s average for a month minus the S&P 500’s average for that same month — isolating Incyte Corporation’s own seasonal edge from broad market drift.
Reality check
Over the last 5 years, June has closed higher 100% of the time versus 70% across the last 10 years — the pattern is strengthening.
Figures are the typical (median) June return and how often it rose — the last 5 years versus the last 10(the heatmap’s default window). This verdict stays anchored to that 10-year window even if you zoom the chart, so it never disagrees with the badges above.
In plain English
Strip the year back and a single month does the heavy lifting: June, up in 7 of 10 Junes while the other eleven tend to blur together.
Its average (+1.0%) and median (+1.4%) land within a hair of each other — the tell of steady, year-after-year gains rather than one outlier doing the work. It is also the calendar's calmest month, its returns swinging least from year to year (a 3.5% spread), and even its worst June in 10 years lost only 6.1% — the gentlest downside anywhere on its calendar. Crucially, the gain is the stock's own rather than a rising tide's: June has cleared the S&P 500 by +0.8 points above the index. That consistency sets it apart from the field, where the average stock manages June only about 52% of the time.
The strength clusters rather than stands alone — May–July forms a firm stretch that carries much of the year. At the other end of the calendar, September has been the soft spot — the weakest of 4 months that average a loss (−4.6%), and the edge isn't year-round — the stock has trailed the S&P 500 in September, April, and March. Its roughest month on record was a −31.7% January in 2016 — a reminder of how hard even a seasonal name can fall.
June has now closed higher 7 years running. If anything it has sharpened recently — the last five Junes run ahead of the earlier years.
The takeaway is less about when to buy than what to expect: June aside, the stock's months offer little reliable tilt.
Short answers on the stock's best month (June), its worst (September), and whether it really trades seasonally.
Yes, to a moderate degree. Since 2016 its best month (June, +1.0%) has run well ahead of its worst (September, −4.6%) — the heatmap above shows how steady that gap has been year to year.
June has been the strongest, averaging +1.0% and closing higher in 7 of 10 years since 2016.
It's the weakest, averaging −4.6% — historically a soft spot, though it still varies from year to year.
Explore
These names have the strongest July track records on record — a starting point for comparison.
Before you trade